相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Targeting telomerase for cancer therapy
Adam N. Guterres et al.
ONCOGENE (2020)
TERT promoter mutation determines apoptotic and therapeutic responses of BRAF-mutant cancers to BRAF and MEK inhibitors: Achilles Heel
Jie Tan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Mechanisms underlying the activation of TERT transcription and telomerase activity in human cancer: old actors and new players
Xiaotian Yuan et al.
ONCOGENE (2019)
TRAIL induces apoptosis but not necroptosis in colorectal and pancreatic cancer cells preferentially via the TRAIL-R2/DR5 receptor
Zuzana Nahacka et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2018)
Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer
Rengyun Liu et al.
NATURE COMMUNICATIONS (2018)
Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner
Andrew Mancini et al.
CANCER CELL (2018)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
TERT promoter mutations and long telomere length predict poor survival and radiotherapy resistance in gliomas
Ke Gao et al.
ONCOTARGET (2016)
TERT promoter mutations in thyroid cancer
Rengyun Liu et al.
ENDOCRINE-RELATED CANCER (2016)
Telomerase reverse transcriptase promotes cancer cell proliferation by augmenting tRNA expression
Ekta Khattar et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancers
Josh Lewis Stern et al.
GENES & DEVELOPMENT (2015)
Development and Characterization of Six New Human Papillary Thyroid Carcinoma Cell Lines
Ying C. Henderson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
Robert J. A. Bell et al.
SCIENCE (2015)
Cancer-associated TERT promoter mutations abrogate telomerase silencing
Kunitoshi Chiba et al.
ELIFE (2015)
A novel two-step genome editing strategy with CRISPR-Cas9 provides new insights into telomerase action and TERT gene expression
Linghe Xi et al.
GENOME BIOLOGY (2015)
TERT Promoter Mutation Status as an Independent Prognostic Factor in Cutaneous Melanoma
Klaus G. Griewank et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Highly prevalent TERT promoter mutations in aggressive thyroid cancers
Xiaoli Liu et al.
ENDOCRINE-RELATED CANCER (2013)
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
Patrick J. Killela et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
TERT Promoter Mutations in Familial and Sporadic Melanoma
Susanne Horn et al.
SCIENCE (2013)
Highly Recurrent TERT Promoter Mutations in Human Melanoma
Franklin W. Huang et al.
SCIENCE (2013)
Telomerase: central regulator of all of the hallmarks of cancer
Kee Chung Low et al.
TRENDS IN BIOCHEMICAL SCIENCES (2013)
Induction of Sodium/Iodide Symporter (NIS) Expression and Radioiodine Uptake in Non-Thyroid Cancer Cells
Zhi Liu et al.
PLOS ONE (2012)
Treatment of arthritis with a selective inhibitor of c-Fos/activator protein-1
Yukihiko Aikawa et al.
NATURE BIOTECHNOLOGY (2008)
Protocol for the fast chromatin immunoprecipitation (ChIP) method
Joel D. Nelson et al.
NATURE PROTOCOLS (2006)
Telomerase confers resistance to caspase-mediated apoptosis
Yira Bermudez et al.
CLINICAL INTERVENTIONS IN AGING (2006)
TERT regulates cell survival independent of telomerase enzymatic activity
Y Cao et al.
ONCOGENE (2002)
An anti-apoptotic protein human survivin is a direct inhibitor of caspase-3 and-7
S Shin et al.
BIOCHEMISTRY (2001)
TRAIL receptor-2 signals apoptosis through FADD and caspase-8
JL Bodmer et al.
NATURE CELL BIOLOGY (2000)
分享论文
